These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3927050)

  • 1. [Mechanism of action of nitroglycerin in stenocardia].
    Trotsiuk VV; Kurochkin NN; Trifonov IuV
    Kardiologiia; 1985 Apr; 25(4):108. PubMed ID: 3927050
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nitrite therapy of stenocardia].
    Meesmann W; Amann L
    Dtsch Med Wochenschr; 1971 Sep; 96(36):1444-9. PubMed ID: 4397998
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with the use of nitroderm--a prolonged-action nitroglycerin preparation].
    Mikunis RI; Monastyrskiĭ IuI; Zhebel' VN; Serkova VK; Bogach NT
    Kardiologiia; 1987 Mar; 27(3):99-101. PubMed ID: 3108565
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinico-functional characteristics of stenocardia and the effectiveness of its treatment with nitrong and erinit].
    Volkov VS; Bratoliubov VP
    Ter Arkh; 1986; 58(5):124-7. PubMed ID: 3090730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamic effects of nitroglycerin].
    Kukes VG; Zisel'man SB; Burian EF; Khang V; Kireeva NA
    Klin Med (Mosk); 1981 Nov; 59(11):22-5. PubMed ID: 6798298
    [No Abstract]   [Full Text] [Related]  

  • 6. [The efficacy of prolonged-action nitrates in stenocardia].
    Shelest AN; Shapkin EI; Cherevatov BG; Kucherenko OD; Matlakhov AN
    Vrach Delo; 1989 Aug; (8):12-3. PubMed ID: 2511663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The hemodynamic action of effective doses of sustak in patients with stenocardia of effort].
    Volkov NF; Snezhitskiĭ VA; Boreĭsho DE; Rakov AV; Kureĭsha AK; Gushcha IM
    Ter Arkh; 1990; 62(9):41-3. PubMed ID: 2126397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of nitroglycerin-retard on central and peripheral hemodynamics, microcirculation and hemostasis].
    Solov'eva FV; Kirichenko LL; Smirnov VV; Kurakina TI; Shchadrintseva MI
    Sov Med; 1987; (8):3-5. PubMed ID: 3122332
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-anginal and hemodynamic effects of single doses of propranolol, verapamil and nitroglycerin-depot in patients with stenocardia].
    Manak NA; Prokopchuk VP; Laziuk DG
    Kardiologiia; 1988 Mar; 28(3):57-60. PubMed ID: 3132571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of anti-anginal action of nitroglycerin].
    Nagasaki F; Yamaguchi H; Nakanishi S; Nishiyama S; Shiratori K
    Nihon Naika Gakkai Zasshi; 1983 Jul; 72(7):859-65. PubMed ID: 6420486
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiologic assessment of the hemodynamic effects of sustained release nitroglycerin in patients with angina pectoris.
    Thompson EJ; Glass P; Torres C; Arora J; Piccone VA
    Angiology; 1973 Sep; 24(8):508-14. PubMed ID: 4199545
    [No Abstract]   [Full Text] [Related]  

  • 12. [Management of stenocardia using hexobendine].
    Schramek G
    Wien Klin Wochenschr; 1972 Feb; 84(6):96-8. PubMed ID: 4621784
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of nitroglycerin ointment on the exercise capacity in patients with angina pectoris.
    Davidov ME; Mroczek WJ
    Angiology; 1976 Apr; 27(4):205-11. PubMed ID: 830062
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of nitroglycerin on the cardiovascular system].
    Dubiel JP
    Folia Med Cracov; 1989; 30(1-2):3-12. PubMed ID: 2518364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-anginal action, by opposite mechanisms, of nitroglycerin and propranolol].
    Giani P; Folli G; Bruno L; Binaghi G; Rizzato GF; Bandera L
    Cuore Circ; 1969 Oct; 53(5):213-32. PubMed ID: 4984065
    [No Abstract]   [Full Text] [Related]  

  • 16. The anti-anginal effect of a new Hungarian long-acting nitroglycerin drug (Nitromint retard) in stable effort angina pectoris.
    Antalóczy Z; Kékes E; Medvegy M; Dénes F; Görgényi F
    Ther Hung; 1987; 35(1):8-13. PubMed ID: 3125624
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous nitroglycerin for rest angina. Potential pathophysiologic mechanisms of action.
    DePace NL; Herling IM; Kotler MN; Hakki AH; Spielman SR; Segal BL
    Arch Intern Med; 1982 Oct; 142(10):1806-9. PubMed ID: 6812520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of ethyl cinepazate maleate on the exercise tolerance test in patients with angina pectoris].
    Cherchi A; Fonzo R; Mercuro G; Lai C
    Boll Soc Ital Cardiol; 1978; 23(1):265-80. PubMed ID: 113021
    [No Abstract]   [Full Text] [Related]  

  • 19. The hemodynamic rationale of propranolol and nitroglycerin in the management of angina pectoris.
    Wiener L
    Med Times; 1970 Jun; 98(6):129-35. PubMed ID: 4986540
    [No Abstract]   [Full Text] [Related]  

  • 20. [Duration of the hemodynamic effect of various doses of delayed-action nitroglycerin preparations].
    Savvateev KL; Metelitsa VI; Vygodin VA
    Kardiologiia; 1983 Feb; 23(2):55-61. PubMed ID: 6405071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.